Measures of Association
|
|
- Angelica Russell
- 5 years ago
- Views:
Transcription
1 Research 101 Series May 2014 Measures of Association Somjot S. Brar, MD, MPH 1,2,3 * Abstract Measures of association are used in clinical research to quantify the strength of association between variables, often an outcome and treatment or outcome and exposure. Frequently the primary results of a study are reported using measures of association, which include: relative risk, risk difference, odds ratio, and hazard ratio. These measures allow for the direction and magnitude of the association between variables to be characterized using a single statistic. The relative risk and risk difference can be calculated from simple 2x2 tables. The hazards ratio is calculated using regression methods. The odds ratio can be calculated from either a 2x2 table or using regression. This article will define measures of association used in clinical research and provide guidance on selecting which to use. Keywords Relative risk Risk difference Odds ratio Hazard ratio 1 Regional Research Committee, Dept. of Research and Evaluation, Kaiser Permanente, Pasadena, CA 2 Department of Cardiology, Kaiser Permanente, Los Angeles, CA 3 Assistant Clinical Professor of Medicine, UCLA *Corresponding author: sbrar@cvri.org Contents Introduction 1 1 Relative Risk 1 2 Risk Difference 2 3 Odds Ratio 3 4 Hazard Ratio 4 Summary 4 Introduction Measures of association are ubiquitous across all fields of clinical research. You have encountered this term countless number of times, perhaps without realizing it. The measures of association are statistics that are used to describe the relationship between two variables, often treatment and outcome or exposure and outcome. This statistic provides insight into the direction and magnitude of the association between variables. Measures of association used in clinical research include: relative risk, risk difference, odds ratio, and hazard ratio. Each of these values is typically reported with a 95% confidence interval. These measures of association are applicable to studies where the outcome or event of interest is binary. That is, events with only two possible outcomes: dead or alive, develop disease or remain disease free. Fortunately this is very common in clinical research. For studies where the outcome is a continuous variable, measures of association discussed in this review are not relevant. 1. Relative Risk Also referred to as the risk ratio, this is the simplest and most intuitive of the measures of association. The relative risk (RR) is simple to compute and interpret; it is the ratio of the event rate in two groups: Relative risk = Event rate group1 Event rate group2 = Event rate treatment Event rate control = Event rate exposed Event rate unexposed Event rates can also be interpreted as probabilities. Therefore the RR can also be defined as the ratio of probabilities for the study groups. In a randomized trial the groups of interest are treatment and control whereas in a registry study they are often labeled exposed and unexposed. Event rates by group are easily calculated from a 2 x 2 table: Dead Alive Treatment A B A+B Control C D C+D A+C B+D In this table the rows represent the study groups and the columns the outcomes. The mortality event rate or probability of death for the treatment group is A/(A + B) and for the control group is C/(C + D). Taking this one step further, the RR from the 2x2 table is defined as the ratio of the two event
2 Measures of Association 2/5 rates or probabilities: RR = Event rate treatment A/(A + B) = Event rate control C/(C + D) You have probably seen findings from clinical trials reported using the RR. Following is an example of how the RR may be reported: The relative risk for aspirin users vs. non-users for myocardial infarction is This one brief statement identifies the two variables for which the association is being reported, aspirin use and myocardial infarction, and using one statistic (RR=0.40) conveys the strength and direction of this association. Since the RR is < 1, aspirin is favored. The RR in this example can be calculated from the raw data as follows: Relative Risk = Event rate aspirin user Event rate aspirin nonuser = 4% 10% = = 0.40 This means that the risk of myocardial infarction among aspirin users is 60% lower compared to non-users. For relative risks < 1.0, subtract the RR from 1 to obtain the percent reduction: Percent Reduction = 1 RR By convention, the numerator contains the treatment or exposed group and the denominator the control or unexposed group. The later is referred to as the referent group. Shown is the RR taking non-diabetics as referent: Relative Risk = Event rate diabetic Event rate non diabetic = 15% 5% = = 3.0 Lets assume a researcher is interested in reporting the primary outcome of a clinical trial by diabetes status. Shown is the relative risk taking diabetics as referent: Relative Risk = Event rate non diabetic Event rate diabetic = 5% 15% = = It s important to identify the control or referent group (the group in the denominator) clearly. Reporting the relationship as a RR for diabetics vs. non-diabetics or non-diabetics vs. diabetics is fine. However, be clear about the order of the relationship otherwise someone reviewing your work (or even possibly you) might be confused. Most often the group of interest (treated or exposed) is placed in the numerator. Because the RR is intuitive and easy to interpret, it is recommended it be used whenever possible. Conditions that should generally be satisfied for the relative risk to be used are: 1. No loss to follow-up 2. Follow-up time is the same for all study participants 3. No need for adjusted measures of association. If an adjustment is necessary consider using odds ratios or hazard ratios. The study design that most often satisfies these conditions is the randomized controlled trial with complete follow-up in all study participants. If the randomization is properly performed the study groups will be very similar in baseline characteristics and there may not be a need to further adjust for differences or imbalances between groups. The RR is commonly used in trials with short follow-up periods where there is (very little or) no loss to follow-up. For example, in a trial exploring the role of a new medication that might reduce the need for blood transfusions during and after cardiac surgery, the outcome is likely to be ascertained in all randomized patients prior to discharge. Limitations However, there are limitations which prohibit using the RR for many studies. When imbalances between study or treatment groups exist researchers often use regression techniques to adjust for these differences. The adjustment is never perfect but can be quite good if carefully thought through. Relative risks do not lend themselves well to regression. Models do exists to do calculate adjusted RR but they can be difficult to work with and sometimes fail to converge and yield an adjusted RR. Thus, it is not common to see adjusted RR used in studies other than clinical trials. 2. Risk Difference The risk difference (RD) is quite meaningful for understanding if findings of a study are worthy of incorporating into clinical practice. If a new very expensive treatment is found to reduce the relative risk for myocardial infarction by 50% we might be very excited about this breakthrough. The RR for a 50% reduction would be Following are two different scenarios that yield the same RR, but have significantly different implications in terms of clinical significance: Rate treatment Rate control RR RD Scenario A 5% 10% % Scenario B 1% 2% % A helpful way to understand the clinical relevance of a therapy is to calculate the number needed to treat (NNT). This is simply the inverse of the RD: NNT = 1 Risk di f f erence The NNT for scenario A is calculated as follows: NNT = = 20
3 Measures of Association 3/5 Note that the RD needs to be in decimal format. This reveals that 20 patients would need to be treated with this new very expensive therapy to prevent one myocardial infarction. For comparison, the NNT for scenario B is 100; thus 100 patients would need to be treated to prevent one event. We would of course want to know more about the treatment: how costly? is it invasive? risks? Integrating these details, along with the RD and NNT, will help us make a more informed decision as to whether the new treatment should be adopted. When the effect of a treatment is assessed in terms of risk difference, the magnitude of the treatment effect often looks less impressive. Thus, many publications do not to report this measure of association. However, the RD provides more insight into the importance of the findings than the RR. Publications often emphasize the RR, but don t forget to calculate the RD and NNT as this is likely more clinically relevant. 3. Odds Ratio The ratio of odds or odds ratio (OR) can be a confusing measure of association. It is easily calculated from a 2x2 table but is more often calculated using logistic regression. If the OR can be calculated using a 2x2 table, then it s probably best to report the RR instead. Before defining the OR, let s define the term odds. Many people are not comfortable thinking in terms of odds. The odds of an event occurring is simply: Odds = p 1 p where p is the probability of the event occurring and 1 p is the probability of the event not occurring. Odds are often used in gambling. For example, the odds of a horse winning may be reported as 20 to 1. This means that for 21 races the horse is expected to lose 20 and win 1. In clinical research, success (1 win) is often stated first and the failure second (20 losses). The probability of a win is thus 1/21 or 4.8% and the odds of winning are 1/20 or 5%. In this case the probability and odds of the outcome are quite similar, but this is not always the case (as is discussed below). The ratio of the odds for the outcome in the study groups (treatment vs. control or exposed vs. unexposed) yields the odds ratio. The OR can also be calculated from a 2x2 table. Following is the familiar 2x2 table: Dead Alive Treatment A B A+B Control C D C+D A+C B+D The odds of dying with treatment from the above table is the probability of the event occurring (A/A + B) divided by the probability of the event not occurring (B/A + B) or simply A/B. The calculation for the odds of dying with control therapy is similar (C/D). The OR is calculated as the ratio of two odds: OR = p/(1 p) treatment p/(1 p) control = A/B C/D = AD BC Odds ratio is often used when RR is not appropriate for the reasons previously outlined. Also, the OR is the appropriate measure of association for case-control studies. When there is suspected imbalance in baseline characteristics between study groups, as is routinely the case in registry studies, OR prove quite useful. In a registry study the treatment or exposure is not randomly assigned. A patient is likely to receive specific treatments because it is in the patient s best interest as determined by the treating physician. This selection bias creates important imbalances between the groups being compared, and when not accounted for yields misleading or biased measures of association. The problem with imbalances or differences between groups is that this can have a profound impact on the study outcome. For example, a study reports that aspirin is ineffective at decreasing the rate of myocardial infarction in patients with known coronary artery disease. However, aspirin users were on average 15 years older than non-users. Knowing this, you are probably not surprised with the result given the marked difference in age between aspirin users and non-users. When a variable is different between groups and influences the outcome it is referred to as a confounder. Not all variables that are different between groups are confounders. For example, if the non-users were more likely to have green eyes, it is irrelevant. Having green eyes does not increase or decrease the risk of being prescribed aspirin or increase the risk for myocardial infarction. Imbalances in important variables between groups is common in registry studies, retrospective or prospective. There are various methods for dealing with the imbalance. The most common are mathematical models that allow for adjusting for these important differences. The modeling method that yields odds ratios is referred to as logistic regression. Another strategy is to limit or restrict the study population. If the effect of aspirin is being assessed in a registry study of patients with coronary artery disease, restricting the study population to subjects over 65 may create groups with comparable ages. Some authors report and interpret the OR as a RR, which should be discouraged. The OR and RR differ by the term in the denominator. For RR, the denominator is comprised of all subjects whereas for the OR the denominator is comprised of subjects without the outcome of interest. The OR can approximate the RR when the probability of the outcome is rare ( < 10%). However the OR can be considerably larger than the RR when the probability of the outcome, in the referent group, is common. The following plot illustrates this relationship.
4 Measures of Association 4/5 Table 1. Measures of Association Measure Study type Source Notes RR Clinical trial 2x2 table Simplest to understand Ratio of probabilities in study groups Mathematically intuitive Need complete follow-up for all subjects Is meaningful when study groups are balanced or similar RD Clinical trial 2x2 table Useful for understanding clinical significance Use to calculate NNT OR Clinical trial 2x2 table Less intuitive than RR Registry study Logistic regression Ratio of odds in study groups Useful when there is imbalance between groups Use when outcome is binary (yes/no; dead/alive) Use when time-to-event is not relevant or important To identify predictors of outcome Must use for case-control studies HR Clinical trial Cox proportional Use when time to event is relevant Registry study hazards model Use when follow-up times are variable Used when there is loss to follow-up Interpretation is similar to RR Mathematically complex, let the computer do the work! RR if OR = 2 by base probability referent group. As the probability in the treatment or exposed group reaches 0, the OR approaches 0, and as the probability reaches 1, the OR approaches infinity. Relative Risk Hazard Ratio When time-to-event is important to account for, the hazard ratio (HR) is the preferred measure of association. The HR is generated from a Cox proportional hazards model. This is a mathematically complex regression model that takes into consideration time to event, differences in follow-up time, and loss to follow-up. The HR can be interpreted similar to the RR Probability in reference group For a fixed OR of 2, the corresponding RR ranges between approximately when the probability of the outcome in the reference group is < 10% or For comparison, when the probability of the outcome is high (e.g., 80% or 0.80), the RR is close to 1.2 for a corresponding OR of 2.0. This discrepancy becomes more pronounced for higher OR. In summary, OR should not be interpreted as RR. Also, the RR is constrained by the probability in the referent group (e.g., control or unexposed). For example, if the probability of the event in the control group is 60% or 0.60 then the RR can be no greater than 1/0.60 or In contrast, the OR is not constrained by the probability in the Summary Now that you know the measures of association, you can better understand why some are chosen over others. Sometimes the investigator has considerable latitude in deciding which to use; often the study design dictates which should be used. As you design your own research proposals you will need to decide how to report results. When reading published literature try to understand why certain measures of association were used and if it was the best choice. A summary is provided in table 1. All measures of association should be reported with 95% confidence intervals. Remember, this discussion is relevant to studies with binary outcomes (e.g., dead/alive). When the outcome is a continuous variable the measures of association discussed are not applicable. For retrospective or prospective registry studies, regression analyses should be be used as there will likely be impor-
5 Measures of Association 5/5 tant imbalances between study groups. Regression methods can take into account measured imbalances between groups and yield adjusted measures of association. If you are not interested in the time to event and have not collected data such that specific timing of the endpoints is ascertained then logistic regression is appropriate and the measure of association will be the OR. If weeks, months, or years pass during your study period, there is loss of follow-up, or variable follow-up times then strongly consider reporting hazard ratios. For clinical trials, there is considerable latitude as more than one measure of association may be appropriate, especially when there is no loss to follow-up (RR, OR, HR, RD). However, for the reasons previously discussed it is preferable to use the RR or HR over OR. Use RR if the follow-up is short and complete and the HR if follow-up is longer, incomplete, or their is interest in understanding differences in time-toevent between groups. Use the RD to quantify the clinical significance of study results. The RD and NNT provide added insight into the clinical relevance of differences in outcomes between groups. Disclaimer The views expressed are those of the author and not supported or endorsed by Kaiser Permanente. The articles in this series were written on nights and weekends; while each manuscript has been revised multiple times, it is possible some errors were missed. If you do identify any please these to me. Also any comments or suggestions for future topics. I will try to reply to these the best I can.
Odd cases and risky cohorts: Measures of risk and association in observational studies
Odd cases and risky cohorts: Measures of risk and association in observational studies Tom Lang Tom Lang Communications and Training International, Kirkland, WA, USA Correspondence to: Tom Lang 10003 NE
More informationCommon Measures and Statistics in Epidemiological Literature
E R I C N O T E B O O K S E R I E S Second Edition Common Measures and Statistics in Epidemiological Literature Second Edition Authors: Lorraine K. Alexander, DrPH Brettania Lopes, MPH Kristen Ricchetti-Masterson,
More informationTests for the Odds Ratio in a Matched Case-Control Design with a Binary X
Chapter 156 Tests for the Odds Ratio in a Matched Case-Control Design with a Binary X Introduction This procedure calculates the power and sample size necessary in a matched case-control study designed
More information2019 Quality Payment Program (QPP) Measure Specification and Measure Flow Guide for MIPS Clinical Quality Measures (CQMs)
2019 Quality Payment Program (QPP) Measure Specification and Measure Flow Guide for MIPS Clinical Quality Measures (CQMs) Utilized by Merit-based Incentive Payment System (MIPS) Eligible Clinicians, Groups,
More information2018 Quality Payment Program (QPP) Measure Specification and Measure Flow Guide for Registry Submission of Individual Measures
2018 Quality Payment Program (QPP) Measure Specification and Measure Flow Guide for Registry Submission of Individual Measures Utilized by Individual Eligible Clinicians for Registry Submissions or Clinical
More information2019 Quality Payment Program (QPP) Measure Specification and Measure Flow Guide for Medicare Part B Claims Measures
2019 Quality Payment Program (QPP) Measure Specification and Measure Flow Guide for Medicare Part B Claims Measures Utilized by Merit-based Incentive Payment System (MIPS) Eligible Clinicians 11/20/2018
More informationIntroduction to Meta-Analysis
Introduction to Meta-Analysis by Michael Borenstein, Larry V. Hedges, Julian P. T Higgins, and Hannah R. Rothstein PART 2 Effect Size and Precision Summary of Chapter 3: Overview Chapter 5: Effect Sizes
More informationTIM 50 Fall 2011 Notes on Cash Flows and Rate of Return
TIM 50 Fall 2011 Notes on Cash Flows and Rate of Return Value of Money A cash flow is a series of payments or receipts spaced out in time. The key concept in analyzing cash flows is that receiving a $1
More informationCrash Involvement Studies Using Routine Accident and Exposure Data: A Case for Case-Control Designs
Crash Involvement Studies Using Routine Accident and Exposure Data: A Case for Case-Control Designs H. Hautzinger* *Institute of Applied Transport and Tourism Research (IVT), Kreuzaeckerstr. 15, D-74081
More informationJacob: What data do we use? Do we compile paid loss triangles for a line of business?
PROJECT TEMPLATES FOR REGRESSION ANALYSIS APPLIED TO LOSS RESERVING BACKGROUND ON PAID LOSS TRIANGLES (The attached PDF file has better formatting.) {The paid loss triangle helps you! distinguish between
More informationBinary Options Trading Strategies How to Become a Successful Trader?
Binary Options Trading Strategies or How to Become a Successful Trader? Brought to You by: 1. Successful Binary Options Trading Strategy Successful binary options traders approach the market with three
More informationYannan Hu 1, Frank J. van Lenthe 1, Rasmus Hoffmann 1,2, Karen van Hedel 1,3 and Johan P. Mackenbach 1*
Hu et al. BMC Medical Research Methodology (2017) 17:68 DOI 10.1186/s12874-017-0317-5 RESEARCH ARTICLE Open Access Assessing the impact of natural policy experiments on socioeconomic inequalities in health:
More informationInverted Withdrawal Rates and the Sequence of Returns Bonus
Inverted Withdrawal Rates and the Sequence of Returns Bonus May 17, 2016 by John Walton Advisor Perspectives welcomes guest contributions. The views presented here do not necessarily represent those of
More informationA New Methodology for Measuring Actual to Expected Performance
A New Methodology for Measuring Actual to Expected Performance Jochen Ruß, Institut für Finanz- und Aktuarwissenschaften Daniel Bauer, Georgia State University This talk is based on joint work with Nan
More informationLARGE SIMPLE CLINICAL TRIALS IN INSURANCE SYSTEMS POST-MYOCARDIAL INFARCTION FREE RX EVENT AND ECONOMIC EVALUATION (MI FREEE) TRIAL
LARGE SIMPLE CLINICAL TRIALS IN INSURANCE SYSTEMS POST-MYOCARDIAL INFARCTION FREE RX EVENT AND ECONOMIC EVALUATION (MI FREEE) TRIAL Niteesh K. Choudhry, MD, PhD Associate Professor, Harvard Medical School
More informationYour AARP Personal Guide to Buying Health Insurance. What you should know. BA9802 (3/06)
Your AARP Personal Guide to Buying Health Insurance What you should know. BA9802 (3/06) A word from AARP Health Care Options AARP Health Care Options is happy to offer you this personal guide to buying
More informationSuperiority by a Margin Tests for the Ratio of Two Proportions
Chapter 06 Superiority by a Margin Tests for the Ratio of Two Proportions Introduction This module computes power and sample size for hypothesis tests for superiority of the ratio of two independent proportions.
More informationEquivalence Tests for One Proportion
Chapter 110 Equivalence Tests for One Proportion Introduction This module provides power analysis and sample size calculation for equivalence tests in one-sample designs in which the outcome is binary.
More informationIntroduction To The Income Statement
Introduction To The Income Statement This is the downloaded transcript of the video presentation for this topic. More downloads and videos are available at The Kaplan Group Commercial Collection Agency
More informationCS134: Networks Spring Random Variables and Independence. 1.2 Probability Distribution Function (PDF) Number of heads Probability 2 0.
CS134: Networks Spring 2017 Prof. Yaron Singer Section 0 1 Probability 1.1 Random Variables and Independence A real-valued random variable is a variable that can take each of a set of possible values in
More informationObjectives. 1. Learn more details about the cohort study design. 2. Comprehend confounding and calculate unbiased estimates
Abortion Week 6 1 Objectives 1. Learn more details about the cohort study design 2. Comprehend confounding and calculate unbiased estimates 3. Critically evaluate how abortion is related to issues that
More informationProblem Set #4. Econ 103. (b) Let A be the event that you get at least one head. List all the basic outcomes in A.
Problem Set #4 Econ 103 Part I Problems from the Textbook Chapter 3: 1, 3, 5, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29 Part II Additional Problems 1. Suppose you flip a fair coin twice. (a) List all the
More informationUnder ERISA, the role of fiduciary
Prudent fiduciary decision making is critical to the goal of achieving successful retirement outcomes and delivering meaningful benefits to plan participants. However, fiduciary responsibility under the
More informationPOPULAR IBC TOPICS Notes on Lecture 4: Paying Cash vs. IBC. Robert P. Murphy July, 2015
POPULAR IBC TOPICS Notes on Lecture 4: Paying Cash vs. IBC Robert P. Murphy July, 2015 REVIEW FROM MANUAL: (Taken from SOL-II in the Course Manual.) Here we can be brief, because I reviewed Nelson s diagram
More informationAn Enhanced On-Level Approach to Calculating Expected Loss Costs
An Enhanced On-Level Approach to Calculating Expected s Marc B. Pearl, FCAS, MAAA Jeremy Smith, FCAS, MAAA, CERA, CPCU Abstract. Virtually every loss reserve analysis where loss and exposure or premium
More informationOverview of CQI modeling for risk adjustment: Motivation and central concepts
Overview of CQI modeling for risk adjustment: Motivation and central concepts Mark E. Cohen, PhD Continuous Quality Improvement American College of Surgeons This presentation s motivation Provide an accessible
More informationAllergies None Penicillin Sulfa Drugs Codeine Aspirin Tape Latex Iodine-Shellfish. Other allergies: Medications
Today s Date: Height Weight Shoe size (CIRCLE) Allergies None Penicillin Sulfa Drugs Codeine Aspirin Tape Latex Iodine-Shellfish Other allergies: Medications SOCIAL HISTORY (CIRCLE) Do you smoke? No Yes
More informationUpdates in ACS NSQIP Modeling, July 24, Mark E. Cohen, PhD Continuous Quality Improvement American College of Surgeons
Updates in ACS NSQIP Modeling, July 24, 2012 Mark E. Cohen, PhD Continuous Quality Improvement American College of Surgeons Overview What is a statistical model and why is it needed? 1. The central task
More information1 Variables and data types
1 Variables and data types The data in statistical studies come from observations. Each observation generally yields a variety data which produce values for different variables. Variables come in two basic
More informationName For those going into. Algebra 1 Honors. School years that begin with an ODD year: do the odds
Name For those going into LESSON 2.1 Study Guide For use with pages 64 70 Algebra 1 Honors GOAL: Graph and compare positive and negative numbers Date Natural numbers are the numbers 1,2,3, Natural numbers
More informationHEALTHCARE EXPENDITURE IN THE LAST YEAR OF LIFE
w w w. I C A 2 0 1 4. o r g HEALTHCARE EXPENDITURE IN THE LAST YEAR OF LIFE AN ACTUARIAL PERSPECTIVE Research Objectives To highlight the key concepts and challenges. To investigate the relationship between
More informationArticle from. Predictive Analytics and Futurism. June 2017 Issue 15
Article from Predictive Analytics and Futurism June 2017 Issue 15 Using Predictive Modeling to Risk- Adjust Primary Care Panel Sizes By Anders Larson Most health actuaries are familiar with the concept
More informationEstimating measurement error when annualizing health care costs
bs_bs_banner Journal of Evaluation in Clinical Practice ISSN 1365-2753 Estimating measurement error when annualizing health care costs Ariel Linden DrPH 1,2 and Steven J. Samuels PhD 3 1 President, Linden
More informationPROBABILITY ODDS LAWS OF CHANCE DEGREES OF BELIEF:
CHAPTER 6 PROBABILITY Probability is the number of ways a particular outcome can occur divided by the number of possible outcomes. It is a measure of how often we expect an event to occur in the long run.
More informationStrategies for Assessing Health Plan Performance on Chronic Diseases: Selecting Performance Indicators and Applying Health-Based Risk Adjustment
Strategies for Assessing Health Plan Performance on Chronic Diseases: Selecting Performance Indicators and Applying Health-Based Risk Adjustment Appendix I Performance Results Overview In this section,
More informationGame Theory I. Author: Neil Bendle Marketing Metrics Reference: Chapter Neil Bendle and Management by the Numbers, Inc.
Game Theory I This module provides an introduction to game theory for managers and includes the following topics: matrix basics, zero and non-zero sum games, and dominant strategies. Author: Neil Bendle
More informationOptimal Risk Adjustment. Jacob Glazer Professor Tel Aviv University. Thomas G. McGuire Professor Harvard University. Contact information:
February 8, 2005 Optimal Risk Adjustment Jacob Glazer Professor Tel Aviv University Thomas G. McGuire Professor Harvard University Contact information: Thomas G. McGuire Harvard Medical School Department
More informationTECHNICAL APPENDIX 1 THE FUTURE ELDERLY MODEL
TECHNICAL APPENDIX 1 THE FUTURE ELDERLY MODEL To estimate the potential health benefits of PCSK9 inhibitors, we use the Future Elderly Model (FEM), a dynamic microsimulation model developed by Goldman
More informationNon-Inferiority Tests for the Odds Ratio of Two Proportions
Chapter Non-Inferiority Tests for the Odds Ratio of Two Proportions Introduction This module provides power analysis and sample size calculation for non-inferiority tests of the odds ratio in twosample
More informationStatistik for MPH: september Odds, odds ratio, analyse af case control studier (Silva:
Statistik for MPH: 4 27. september 2018 www.biostat.ku.dk/~pka/mph18 Odds, odds ratio, analyse af case control studier (Silva: 203-212.) Per Kragh Andersen 1 Fra den 3. uges statistikundervisning: skulle
More informationHealth Information Technology and Management
Health Information Technology and Management CHAPTER 11 Health Statistics, Research, and Quality Improvement Pretest (True/False) Children s asthma care is an example of one of the core measure sets for
More informationThe Consideration of Projected Income in the Valuation of Noncontrolling Ownership Interests
Gift and Estate Tax Valuation Insights The Consideration of Projected Income in the Valuation of Noncontrolling Ownership Interests Timothy J. Meinhart Most valuations of nonmarketable, noncontrolling
More informationPoint-Biserial and Biserial Correlations
Chapter 302 Point-Biserial and Biserial Correlations Introduction This procedure calculates estimates, confidence intervals, and hypothesis tests for both the point-biserial and the biserial correlations.
More informationChapter 6: Supply and Demand with Income in the Form of Endowments
Chapter 6: Supply and Demand with Income in the Form of Endowments 6.1: Introduction This chapter and the next contain almost identical analyses concerning the supply and demand implied by different kinds
More informationPortfolio Performance Analysis
U.U.D.M. Project Report 2017:17 Portfolio Performance Analysis Elin Sjödin Examensarbete i matematik, 30 hp Handledare: Maciej Klimek Examinator: Erik Ekström Juni 2017 Department of Mathematics Uppsala
More informationSensitivity Analysis for Unmeasured Confounding: Formulation, Implementation, Interpretation
Sensitivity Analysis for Unmeasured Confounding: Formulation, Implementation, Interpretation Joseph W Hogan Department of Biostatistics Brown University School of Public Health CIMPOD, February 2016 Hogan
More informationImplementing Personalized Medicine: Estimating Optimal Treatment Regimes
Implementing Personalized Medicine: Estimating Optimal Treatment Regimes Baqun Zhang, Phillip Schulte, Anastasios Tsiatis, Eric Laber, and Marie Davidian Department of Statistics North Carolina State University
More informationTHE UNIVERSITY OF TEXAS AT AUSTIN Department of Information, Risk, and Operations Management
THE UNIVERSITY OF TEXAS AT AUSTIN Department of Information, Risk, and Operations Management BA 386T Tom Shively PROBABILITY CONCEPTS AND NORMAL DISTRIBUTIONS The fundamental idea underlying any statistical
More informationAppendix D BASIC OBJECTIVES AND GENERAL STANDARDS OF FIDUCIARY ACCOUNTING AND FIDUCIARY ACCOUNTING PRINCIPLES*
Appendix D BASIC OBJECTIVES AND GENERAL STANDARDS OF FIDUCIARY ACCOUNTING AND FIDUCIARY ACCOUNTING PRINCIPLES* BASIC OBJECTIVES AND GENERAL STANDARDS OF FIDUCIARY ACCOUNTING The fundamental objective of
More informationCash Flow and the Time Value of Money
Harvard Business School 9-177-012 Rev. October 1, 1976 Cash Flow and the Time Value of Money A promising new product is nationally introduced based on its future sales and subsequent profits. A piece of
More informationBest Practices in SCAP Modeling
Best Practices in SCAP Modeling Dr. Joseph L. Breeden Chief Executive Officer Strategic Analytics November 30, 2010 Introduction The Federal Reserve recently announced that the nation s 19 largest bank
More informationMeasurable value creation through an advanced approach to ERM
Measurable value creation through an advanced approach to ERM Greg Monahan, SOAR Advisory Abstract This paper presents an advanced approach to Enterprise Risk Management that significantly improves upon
More informationFor over a century the cornerstone of individual
IMPLICATIONS FOR USE OF CREDITS APPLIED TO PREFERRED KNOCK-OUT CRITERIA Doug Ingle, FALU, FLMI Vice President, Underwriting Research Hannover Life Reassurance Company of America Waukesha, WI doug.ingle@hlramerica.com
More informationCity of Los Angeles Periodic Utilization Report 3rd Quarter 2017 (10/1/2016 9/30/2017)
Dr. Craig Collins, MD, MBA, FACS General and Minimally Invasive Surgery Physician Marketing Leader, Los Angeles Metro Area Associate Clinical Professor, UCLA Geffen School of Medicine City of Los Angeles
More informationTable of Contents I. Annuities 2 A. Who... 2 B. What... 2 C. Where... 2 D. When... 3 Annuity Phases... 3 a) Immediate Annuity...
Table of Contents I. Annuities 2 A. Who... 2 B. What... 2 C. Where... 2 D. When... 3 Annuity Phases... 3 a) Immediate Annuity... 3 b) Deferred Annuity... 3 E. Why... 4 F. How do I put my money in?... 4
More informationMorning Client Note Wednesday, September 17, 2014
Morning Client Note Wednesday, September 17, 2014 DOW Futures (RR) $17,035 and head higher to fixed targeted-resistance at $17,100. The overnight low was $17,036 and the overnight high was $17,064. Price
More informationPSYCHOLOGICAL HEALTH ASSOCIATES, PA PSYCHOLOGIST-PATIENT SERVICES.
PSYCHOLOGICAL HEALTH ASSOCIATES, PA PSYCHOLOGIST-PATIENT SERVICES. Welcome to my practice. I am happy to have you as a client. This document (the Agreement) contains important information about my professional
More informationIn physics and engineering education, Fermi problems
A THOUGHT ON FERMI PROBLEMS FOR ACTUARIES By Runhuan Feng In physics and engineering education, Fermi problems are named after the physicist Enrico Fermi who was known for his ability to make good approximate
More informationOne Proportion Superiority by a Margin Tests
Chapter 512 One Proportion Superiority by a Margin Tests Introduction This procedure computes confidence limits and superiority by a margin hypothesis tests for a single proportion. For example, you might
More informationThe Realities of Billing Insurance in the Private Practice Setting
The Realities of Billing Insurance in the Private Practice Setting The Good, The Bad, and The Ugly By Ginger Bailey, RDN, CD Conflict of Interest No conflict of interest are known Objectives Give RDs more
More informationIssue Brief. Does Medicaid Make a Difference? The COMMONWEALTH FUND. Findings from the Commonwealth Fund Biennial Health Insurance Survey, 2014
Issue Brief JUNE 2015 The COMMONWEALTH FUND Does Medicaid Make a Difference? Findings from the Commonwealth Fund Biennial Health Insurance Survey, 2014 The mission of The Commonwealth Fund is to promote
More informationSelection of High-Deductible Health Plans
Selection of High-Deductible Health Plans Attributes Influencing Likelihood and Implications for Consumer- Driven Approaches Wendy Lynch, PhD Harold H. Gardner, MD Nathan Kleinman, PhD 415 W. 17th St.,
More informationECSDA response to the European Commission consultation on conflict of laws rules for third party effects of transactions in securities and claims
Published on 30 June 2017 ECSDA response to the European Commission consultation on conflict of laws rules for third party effects of transactions in securities and claims This paper constitutes European
More informationEffects of global risk in transition countries
TUFI HETA Kleida & KASTRATI Albana & SARAÇI Peter - The exposure of construction firms in Shkodra region to the exchange rate risk and its hedging THE EXPOSURE OF CONSTRUCTION FIRMS IN SHKODRA REGION TO
More informationGamma Distribution Fitting
Chapter 552 Gamma Distribution Fitting Introduction This module fits the gamma probability distributions to a complete or censored set of individual or grouped data values. It outputs various statistics
More informationCHAPTER 17 INVESTMENT MANAGEMENT. by Alistair Byrne, PhD, CFA
CHAPTER 17 INVESTMENT MANAGEMENT by Alistair Byrne, PhD, CFA LEARNING OUTCOMES After completing this chapter, you should be able to do the following: a Describe systematic risk and specific risk; b Describe
More informationTHREE. Interest Rate and Economic Equivalence CHAPTER
CHAPTER THREE Interest Rate and Economic Equivalence No Lump Sum for Lottery-Winner Grandma, 94 1 A judge denied a 94-year-old woman s attempt to force the Massachusetts Lottery Commission to pay her entire
More informationA Spreadsheet-Literate Non-Statistician s Guide to the Beta-Geometric Model
A Spreadsheet-Literate Non-Statistician s Guide to the Beta-Geometric Model Peter S Fader wwwpetefadercom Bruce G S Hardie wwwbrucehardiecom December 2014 1 Introduction The beta-geometric (BG) distribution
More informationA Guide to Retirement Planning Using Annuities. Don t Just Buy an Annuity Buy the Right Annuity! By Brent Meyer
A Guide to Retirement Planning Using Annuities. Don t Just Buy an Annuity Buy the Right Annuity! By Brent Meyer 1 Don t Just Buy an Annuity Buy the Right Annuity! Page Table of Contents What is an Annuity...3
More informationSurvey Sampling, Fall, 2006, Columbia University Homework assignments (2 Sept 2006)
Survey Sampling, Fall, 2006, Columbia University Homework assignments (2 Sept 2006) Assignment 1, due lecture 3 at the beginning of class 1. Lohr 1.1 2. Lohr 1.2 3. Lohr 1.3 4. Download data from the CBS
More informationEconomic evaluations are defined as the comparative analysis of alternative
Nyman Economic Evaluations in Healthcare: Overview, Policy, and Uses John A. Nyman, PhD Overview: The Basics Economic evaluations are defined as the comparative analysis of alternative courses of action
More informationInstitute for Clinical Evaluative Sciences. From the SelectedWorks of Peter Austin. Peter C Austin, Institute for Clinical Evaluative Sciences
Institute for Clinical Evaluative Sciences From the SelectedWorks of Peter Austin 2010 The performance of different propensity-score methods for estimating differences in proportions (risk differences
More informationExhibit A EXAMPLE I: PERFORMANCE TARGETS. The Financial Target will affect 50% of the interest payable under the terms of the Bonds.
Exhibit A EXAMPLE I: PERFORMANCE TARGETS There will be a Financial Target and three Non-Financial Targets, as described below. The Financial Target will affect 50% of the interest payable under the terms
More informationEconomic Decision Making Using Fuzzy Numbers Shih-Ming Lee, Kuo-Lung Lin, Sushil Gupta. Florida International University Miami, Florida
Economic Decision Making Using Fuzzy Numbers Shih-Ming Lee, Kuo-Lung Lin, Sushil Gupta Florida International University Miami, Florida Abstract In engineering economic studies, single values are traditionally
More informationUpper Basin Pallid Sturgeon Survival Estimation Project Update
Upper Basin Pallid Sturgeon Survival Estimation Project 2015 Update Report Updated by Jay Rotella May 2015 Table of Contents Background... 3 Analysis methods... 3 Assumptions of Analysis Approach... 3
More informationMyth: This is going to cost a fortune. How will we pay for it?
Myths About SB 810 & Responses I. AFFORDABILITY Myth: This is going to cost a fortune. How will we pay for it? Response: The current health care finance system wastes nearly 50% of each health care dollar
More informationSelection of High-Deductible Health Plans: Attributes Influencing Likelihood and Implications for Consumer-Driven Approaches
Selection of High-Deductible Health Plans: Attributes Influencing Likelihood and Implications for Consumer-Driven Approaches Wendy D. Lynch, Ph.D. Harold H. Gardner, M.D. Nathan L. Kleinman, Ph.D. Health
More informationProbability, Odds Ratio and Risk Ratio. Dr. Abbas Adigun (PhD) Biostatistician 19 th May 2017
Probability, Odds Ratio and Risk Ratio Dr. Abbas Adigun (PhD) Biostatistician 19 th May 2017 Probability Probability is a measure of the chance of getting some outcome of interest from some event. The
More informationQUALITY OF SOCIAL PROTECTION IN PERU
QUALITY OF SOCIAL PROTECTION IN PERU HUGO ÑOPO 1 1 Economist, Department of Research, Inter-American Development Bank (IADB). 407 INTRODUCTION This presentation is based on the preliminary results of some
More informationHistorical Trends in the Degree of Federal Income Tax Progressivity in the United States
Kennesaw State University DigitalCommons@Kennesaw State University Faculty Publications 5-14-2012 Historical Trends in the Degree of Federal Income Tax Progressivity in the United States Timothy Mathews
More informationPaying for care. KaiSer permanente deductible HMo plan. Learn more about how your deductible plan works at kp.org.
KaiSer permanente deductible HMo plan Paying for care we re here to help you better understand the financial aspects of your deductible plan. understanding your costs can help you feel more comfortable
More informationPanel Data with Binary Dependent Variables
Essex Summer School in Social Science Data Analysis Panel Data Analysis for Comparative Research Panel Data with Binary Dependent Variables Christopher Adolph Department of Political Science and Center
More informationExam M Fall 2005 PRELIMINARY ANSWER KEY
Exam M Fall 005 PRELIMINARY ANSWER KEY Question # Answer Question # Answer 1 C 1 E C B 3 C 3 E 4 D 4 E 5 C 5 C 6 B 6 E 7 A 7 E 8 D 8 D 9 B 9 A 10 A 30 D 11 A 31 A 1 A 3 A 13 D 33 B 14 C 34 C 15 A 35 A
More informationValue-Based Insurance Design
H E A L T H P O L I C Y C E N T E R R E S E A RCH REPORT Payment Methods and Benefit Designs: How They Work and How They Work Together to Improve Health Care Value-Based Insurance Design Suzanne F. Delbanco
More informationEngagement, Incentives, and Impact
Engagement, Incentives, and Impact Wes Alles, Ph.D. Structure of the BeWell incentive Program at Stanford University BeWell engagement from 2008 to 2013 RAND Workplace Wellness Programs Study Answer to
More informationCatherine De Vries, Spyros Kosmidis & Andreas Murr
APPLIED STATISTICS FOR POLITICAL SCIENTISTS WEEK 8: DEPENDENT CATEGORICAL VARIABLES II Catherine De Vries, Spyros Kosmidis & Andreas Murr Topic: Logistic regression. Predicted probabilities. STATA commands
More informationMedicaid and PeachCare for Kids Provider Survey: Customer Service Satisfaction Survey Spring Prepared for ACS
Medicaid and PeachCare for Kids Provider Survey: Customer Service Satisfaction Survey Spring 2004 Prepared for ACS Prepared by the Georgia Health Policy Center At Georgia State University 1 EXECUTIVE SUMMARY...
More informationEconomics 317 Health Economics III Sample questions for midterm examination I February, 2011
University of Victoria Department of Economics Economics 317 Health Economics III Sample questions for midterm examination I February, 2011 1 Multiple guess questions. 1. The RAND Health Insurance Experiment
More informationChapter 5. Sampling Distributions
Lecture notes, Lang Wu, UBC 1 Chapter 5. Sampling Distributions 5.1. Introduction In statistical inference, we attempt to estimate an unknown population characteristic, such as the population mean, µ,
More informationChoosing a Medigap Policy: A Guide to Health Insurance for People with Medicare
CENTERS FOR MEDICARE & MEDICAID SERVICES 2011 Choosing a Medigap Policy: A Guide to Health Insurance for People with Medicare This official government guide has important information about the following:
More informationAnnual Qualification Review
LCCI International Qualifications Level 2 Certificate in Book-Keeping and Accounts Annual Qualification Review 2008 For further information contact us: Tel. +44 (0) 8707 202909 Email. enquiries@ediplc.com
More informationIntersecting roles CMS and FDA implications for pharmaceutical and device industries
Intersecting roles CMS and FDA implications for pharmaceutical and device industries Peter B. Bach, MD, MAPP Senior Adviser, Office of the Administrator Centers for Medicare & Medicaid Services Traditional
More informationFor these reasons, we believe that alternative investments are not for everyone, regardless of their intended purpose in a portfolio.
Investor sedge Second quarter 2019 What is your alternate plan? As anyone who has driven on a dirt road can attest, sometimes the travel can become quite rough due to rain, snow, wind or other inclement
More informationTo be two or not be two, that is a LOGISTIC question
MWSUG 2016 - Paper AA18 To be two or not be two, that is a LOGISTIC question Robert G. Downer, Grand Valley State University, Allendale, MI ABSTRACT A binary response is very common in logistic regression
More informationWhy casino executives fight mathematical gambling systems. Casino Gambling Software: Baccarat, Blackjack, Roulette, Craps, Systems, Basic Strategy
Why casino executives fight mathematical gambling systems Casino Gambling Software: Baccarat, Blackjack, Roulette, Craps, Systems, Basic Strategy Software for Lottery, Lotto, Pick 3 4 Lotteries, Powerball,
More informationWeighted mortality experience analysis
Mortality and longevity Tim Gordon, Aon Hewitt Weighted mortality experience analysis 2010 The Actuarial Profession www.actuaries.org.uk Should weighted statistics be used in modern mortality analysis?
More informationNon-Inferiority Tests for the Difference Between Two Proportions
Chapter 0 Non-Inferiority Tests for the Difference Between Two Proportions Introduction This module provides power analysis and sample size calculation for non-inferiority tests of the difference in twosample
More informationComparing Costs and Policy Illustrations
Comparing Costs and Policy Illustrations 6 Learning Objectives An understanding of the material in this chapter should enable you to 6-1. List and explain the methods of comparing life insurance policies,
More informationWhat is the Lasting Powers of Attorney service?
What is the Lasting Powers of Attorney service? Wrigleys Lasting Powers of Attorney Service is dedicated to helping people put powers of attorney in place that suit their personal circumstances. Wrigleys
More informationNon-Inferiority Tests for the Ratio of Two Proportions
Chapter Non-Inferiority Tests for the Ratio of Two Proportions Introduction This module provides power analysis and sample size calculation for non-inferiority tests of the ratio in twosample designs in
More information